China gives conditional approval for CNBG's COVID-19 vaccine

China has given conditional approval for general public use to a COVID-19 vaccine developed by China National Biotec Group (CNBG), an official with China's National Medical Products Administration told a media briefing on Thursday.

The approval is the first for general public use among a handful of Chinese coronavirus vaccine candidates in various stages of development.

Also Read: Gucci joins Alibaba's luxury e-commerce site to woo Chinese consumers

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)